6HN6 image
Deposition Date 2018-09-14
Release Date 2019-02-20
Last Version Date 2024-06-19
Entry Detail
PDB ID:
6HN6
Keywords:
Title:
A revisited version of the apo structure of the ligand-binding domain of the human nuclear receptor RXR-ALPHA
Biological Source:
Source Organism:
Homo sapiens (Taxon ID: 9606)
Method Details:
Experimental Method:
Resolution:
2.71 Å
R-Value Free:
0.23
R-Value Work:
0.17
R-Value Observed:
0.17
Space Group:
P 63 2 2
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:Retinoic acid receptor RXR-alpha
Gene (Uniprot):RXRA
Chain IDs:A
Chain Length:282
Number of Molecules:1
Biological Source:Homo sapiens
Ligand Molecules
Primary Citation
A revisited version of the apo structure of the ligand-binding domain of the human nuclear receptor retinoic X receptor alpha.
Acta Crystallogr F Struct Biol Commun 75 98 104 (2019)
PMID: 30713160 DOI: 10.1107/S2053230X18018022

Abstact

The retinoic X receptor (RXR) plays a crucial role in the superfamily of nuclear receptors (NRs) by acting as an obligatory partner of several nuclear receptors; its role as a transcription factor is thus critical in many signalling pathways, such as metabolism, cell development, differentiation and cellular death. The first published structure of the apo ligand-binding domain (LBD) of RXRα, which is still used as a reference today, contained inaccuracies. In the present work, these inaccuracies were corrected using modern crystallographic tools. The most important correction concerns the presence of a π-bulge in helix H7, which was originally built as a regular α-helix. The presence of several CHAPS molecules, which are visible for the first time in the electron-density map and which stabilize the H1-H3 loop, which contains helix H2, are also revealed. The apo RXR structure has played an essential role in deciphering the molecular mode of action of NR ligands and is still used in numerous biophysical studies. This refined structure should be used preferentially in the future in interpreting experiments as well as for modelling and structural dynamics studies of the apo RXRα LBD.

Legend

Protein

Chemical

Disease

Primary Citation of related structures